Literature DB >> 6510596

Sorbitol accumulation is altered in type 1 (insulin-dependent) diabetes mellitus.

J I Malone, G Knox, C Harvey.   

Abstract

Intracellular sorbitol accumulation has been implicated as an aetiological factor for many of the complications of diabetes mellitus. Erythrocyte sorbitol is found in higher concentration in Type 1 (insulin-dependent) diabetic patients than in normal subjects. When sorbitol accumulation is corrected for its immediate precursor glucose (sorbitol/glucose ratio), the polyol accumulation remains significantly greater in erythrocytes from the Type 1 diabetic. Erythrocytes from Type 1 diabetic patients exposed to normal extracellular glucose concentrations for 3 h in vitro, accumulate more sorbitol and fructose than normal cells in the same incubation system. Near-normalization of plasma glucose in Type 1 diabetic patients for 12 h did not result in normal erythrocyte sorbitol levels. The increased sorbitol accumulation in erythrocytes from Type 1 diabetic subjects may reflect similar activity in the lens and nerve in long-standing diabetes. This increased sorbitol production was found in most, but not all, individuals with diabetes and appears to be an acquired characteristic. Those factors influencing enhanced tissue sorbitol accumulation may be important in the aetiology of diabetes-associated complications.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510596     DOI: 10.1007/bf00290385

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Polyol pathway in aorta: regulation by hormones.

Authors:  R S Clements; A D Morrison; A I Winegrad
Journal:  Science       Date:  1969-11-21       Impact factor: 47.728

Review 2.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

3.  Purification and immunologic identification of aldose reductases.

Authors:  K H Gabbay; E S Cathcart
Journal:  Diabetes       Date:  1974-05       Impact factor: 9.461

4.  Effects of elevated glucose concentrations on the metabolism of the aortic wall.

Authors:  A D Morrison; R S Clements; A I Winegrad
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

5.  Glucose utilization by the polyol pathway in human erythrocytes.

Authors:  A D Morrison; R S Clements; S B Travis; F Oski; A I Winegrad
Journal:  Biochem Biophys Res Commun       Date:  1970-07-13       Impact factor: 3.575

6.  Affinity chromatography of bovine lens aldose reductase, and a comparison of some kinetic properties of the enzyme from lens and human erythrocyte [proceedings].

Authors:  M J Crabbe; A B Halder
Journal:  Biochem Soc Trans       Date:  1980-04       Impact factor: 5.407

7.  Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway.

Authors:  S F Travis; A D Morrison; R S Clements; A I Winegrad; F A Oski
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

8.  The reduction of glyceraldehyde by human erythrocytes. L-hexonate dehydrogenase activity.

Authors:  E Beutler; E Guinto
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects.

Authors:  J I Malone; H Leavengood; M J Peterson; M M O'Brien; M G Page; C E Aldinger
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

10.  Red cell sorbitol: an indicator of diabetic control.

Authors:  J I Malone; G Knox; S Benford; T A Tedesco
Journal:  Diabetes       Date:  1980-11       Impact factor: 9.461

View more
  5 in total

1.  Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.

Authors:  D Bareford; P E Jennings; P C Stone; S Baar; A H Barnett; J Stuart
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

2.  Human erythrocyte sorbitol metabolism and the role of sorbitol dehydrogenase.

Authors:  Y Nagasaka; S Fujii; T Kaneko
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

Review 3.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

4.  Early manifestation of cataract in a child heterozygous for classical galactosaemia and with diabetes mellitus type I: increased plasma mannitol concentration in cataract patients.

Authors:  Y S Shin; K Reiter; A Urban; B Lorenz; W Kiess
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 5.  Research progress on the relationship between autophagy and chronic complications of diabetes.

Authors:  Xia Ge; Ling Wang; Aihua Fei; Shandong Ye; Qingping Zhang
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.